Literature DB >> 23099177

Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone.

Bjørnar den Hollander1, Stanislav Rozov, Anni-Maija Linden, Mikko Uusi-Oukari, Ilkka Ojanperä, Esa R Korpi.   

Abstract

INTRODUCTION/AIMS: The use of cathinone-derivative designer drugs methylone and mephedrone has increased rapidly in recent years. Our aim was to investigate the possible long-term effects of these drugs on a range of behavioral tests in mice. Further, we investigated the long-term effects of these drugs on brain neurochemistry in both rats and mice.
METHODS: We treated animals with a binge-like regimen of methylone or mephedrone (30 mg/kg, twice daily for 4 days) and, starting 2 weeks later, we performed behavioral tests of memory, anxiety and depression and measured brain levels of dopamine (DA), serotonin (5-HT), their metabolites and norepinephrine (NE). 5-HT and DA transporter (5-HTT and DAT) levels were also measured in rats by [(3)H]paroxetine and [(3)H]mazindol binding.
RESULTS: Mephedrone reduced working memory performance in the T-maze spontaneous alternation task but did not affect neurotransmitter levels aside from a 22% decrease in striatal homovanillic acid (HVA) levels in mice. Methylone had little effect on behavior or neurotransmitter levels in mice but produced a widespread depletion of 5-HT and 5-HTT levels in rats.
CONCLUSIONS: Both methylone and mephedrone appeared to have a long-term effect on either behavioral or biochemical gauges of neurotoxicity in rodents.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23099177     DOI: 10.1016/j.pbb.2012.10.006

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  42 in total

1.  Intravenous self-administration of entactogen-class stimulants in male rats.

Authors:  Sophia A Vandewater; Kevin M Creehan; Michael A Taffe
Journal:  Neuropharmacology       Date:  2015-08-21       Impact factor: 5.250

2.  Mephedrone alters basal ganglia and limbic dynorphin systems.

Authors:  Christopher L German; Mario E Alburges; Amanda J Hoonakker; Annette E Fleckenstein; Glen R Hanson
Journal:  Synapse       Date:  2014-09-08       Impact factor: 2.562

Review 3.  Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

Authors:  Christopher L German; Annette E Fleckenstein; Glen R Hanson
Journal:  Life Sci       Date:  2013-08-02       Impact factor: 5.037

Review 4.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

5.  The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.

Authors:  Nicholas B Miner; James P O'Callaghan; Tamara J Phillips; Aaron Janowsky
Journal:  Neurotoxicol Teratol       Date:  2017-02-16       Impact factor: 3.763

6.  Substituted methcathinones differ in transporter and receptor interactions.

Authors:  Amy J Eshleman; Katherine M Wolfrum; Meagan G Hatfield; Robert A Johnson; Kevin V Murphy; Aaron Janowsky
Journal:  Biochem Pharmacol       Date:  2013-04-10       Impact factor: 5.858

Review 7.  Neurotoxicology of Synthetic Cathinone Analogs.

Authors:  Mariana Angoa-Pérez; John H Anneken; Donald M Kuhn
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 8.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

9.  Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.

Authors:  John H Anneken; Mariana Angoa-Perez; Girish C Sati; David Crich; Donald M Kuhn
Journal:  Neuropharmacology       Date:  2017-08-26       Impact factor: 5.250

Review 10.  Behavioral pharmacology of designer cathinones: a review of the preclinical literature.

Authors:  Ryan A Gregg; Scott M Rawls
Journal:  Life Sci       Date:  2013-11-11       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.